Adaptive Intelligent Systems, LLC
Advanced Semiconductor Processing Technology
Zhi David Chen
Based on research by Zhi David Chen, Center for Nanoscale Science & Engineering
Advanced Semiconductor Processing Technology’s current product is a dew point sensor which is based upon research on semiconductor processing technology and its applications on electronic devices including sensors and transistors. The company has also developed a new type of moisture sensor called alpha-Al2O3 based dew point.
Bluegrass Advanced Material, LLC
Joe Wyse, Chief Executive Officer, email@example.com, (859)948-4716
Bluegrass Advanced Materials (BAM) is developing naturally derived antioxidant polymers that will be used in many commercial applications. Our strategy is to develop our own BAM products and supply technology to existing business to improve commercial products.
Based on research from the Center for Microelectrode Technology, Greg Gerhardt director, Peter Huettl assistant director
Developing a new generation of clinical diagnostic devices for patients with epilepsy and traumatic brain injury.
Todd Hastings, CEO, 859.576.4951
Coplex Therapeutics, LLC
Dr. Lin Yang, firstname.lastname@example.org, 859-218-6535
CytoInformatics, LLC is a technology company that specializes in extracting insights from microscopic images. Our unique services combine cutting-edge computer vision technology with human expertise to provide the most robust, accurate, and customizable image analysis possible.
Fawkes Biotechnology, LLC
GISMO Therapeutic, Inc.
Paul Gregory, Ph.D., President, 347-251-7342
Gismo Therapeutics is developing new oral therapeutics for Alzheimer's and Parkinson's diseases, based on a new technology platform (GISMO) targeting glycosaminoglycans.
The company is funded by grants and a private investor.
Mukesh Agarwal, President, 216.496.9053
Invenio Therapeutics Inc. is an early-stage biopharmaceutical company developing novel drug compounds that terminally differentiate leukemia cells so that they no longer have the ability to divide and replicate. Invenio's focus is R&D on cutting-edge drug treatments targeting Acute Myeloid Leukemia (AML), for which no cure exists.
Minerva Systems & Technologies
Kalyan Ganesan, Chief Technology Officer, 859.489.0156 or 859.218.6569
Minerva Systems & Technologies, LLC is an emerging technology company with expertise in navigation and guidance, satellite & wireless communications, signal processing, and embedded hardware and software design and development.
Based on research by Patrick Sullivan / SCoBIRC and anatomy & neurobiology
R&D to control obesity using nanotechnology to alter the body's metabolic rate and increase the cell's ability to convert sugar to energy. Research could lead to future breakthroughs in the treatment of traumatic central nervous system damage and neurodegenerative disorders.
Based on research by John Littleton / molecular pharmacology and plant genomics
Commercialized technology that enables bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's current focus is on non-toxic insecticides, CNS-acting drugs and chemotherapeutic agents.
PowerTech Water, LLC
James Landon, 732-539-0089
PowerTech Water, LLC (PTW) is focused on commercializing a new water treatment technology called inverted capacitive deionization (INCION™).
PTW uses high surface area carbon electrodes and unique surface chemistry to provide long-lasting separation processes for a variety of end users. PTW is dedicated to constructing water treatment units that can produce high purity water for applications such as water softening and industrial treatment. More information can be found on our website: www.powertechwater.com
RAMP Research, LLC
Redleaf Biologics, LLC
Jordan Wood, COO, 205-910-0641
Based on research conducted by RedLeaf's CEO, Seth DeBolt, Ph.D.
RedLeaf is a biomanufacturing startup producing natural food colorants, antimicrobials, and antioxidants for human and livestock applications.
Science Tomorrow LLC
Christopher Etesse, President & CEO, email@example.com, 202-549-7070
Scriyb uses the Power of the Internet to Scale Live Classes. The patented Learning Science along with AI and Machine Learning helps to scale live classes in a more engaging way than traditional learning platforms. Our founder, Dr. Scott Martin, is writing a book chapter on this Learning Science with the likes of Harvard, FB, Google, and others. For a lot of our clients, we are solving the teacher and expert shortage. A lot of Cybersecurity, CISCO, Drones, AR/VR, Game Design, Coding, etc.
Signal Solutions LLC
Bruce F. O'Hara, 859.266.0964
Signal Solutions LLC was formed in February 2009 to sell products and support research associated with their non-invasive, high-throughput sleep-wake tracking system for mice. Currently, several systems are being used in research labs around the world including an 80 cage set-up at The Jackson Laboratory (Bar Harbor, ME) as part of a large-scale NIH U54 project to perform deep phenotyping on individual mouse gene knockouts to better understand these genes and associated diseases. Signal Solutions was chosen as a primary subcontractor for this five year effort referred to as KOMP2 and supported by the International Knockout Mouse Consortium. In April 2013, Signal Solutions was awarded a 2-year Phase I NIH SBIR grant to further extent the capability of its system to track REM and nonREM sleep in addition to other behaviors. Signal Solutions also develops a variety of other hardware and software for assessing physiological variables in mice, horses, and people.
TEC Bioscience, LLC
Voyekov Labs, LLC
Kerry M. Codoley, firstname.lastname@example.org, 859-310-2664
We are an Industrial Hemp extractior, processor, and manufacturer. We specialize in cryogenic primary extraction, molecular filtration, and cannabinoid separation. We are committed to producing a range of products made from Industrial Hemp cannabinoids for a broad market.
W-Z Biotech, founded in 2009 by Dr. Jay Zwischenberger, surgery, and Dr. Dongfang Wang, cardiothoracic surgery, specializes in the development of novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy.